[ad_1]
Jakarta, CNBC Indonesia – The UK is the first country to grant approval for the emergency use of the Pfizer / BioNTech Covid-19 vaccine for use by the general community. With this permission, the vaccine is expected to go on sale to the public next week.
“The government today received a recommendation from the Medicines and Health Products Regulatory Agency (MHRA) to approve the use of the Pfizer-BioNTech Covid-19 vaccine,” the health department said in a statement. ).
“The vaccines will be available across the UK from next week,” the statement said, with priority groups including nursing home residents, health and care staff.
The UK has ordered 20 million doses of the Pfizer vaccine, but it is not yet known how many will arrive this year. This vaccine requires two doses for the body to be immune to Covid-19.
The Pfizer vaccine is up to 95% effective in preventing Covid-19. The production of this vaccine is carried out by the German pharmaceutical company BioNTech. The vaccine is said to be equally effective in all ages and ethnicities.
The expiration date of the Pfizer vaccine is very fast. A cold room with a temperature of minus 70 degrees Celsius is needed and the vaccine can last for 5 days.
[Gambas:Video CNBC]
(Roy / Roy)
